1Goldberg DS, McGee SJ. Pain as a global public health priority [ J ]. BMC Public Health,2011,6( 11 ) :770.
2Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC [ J ]. Lancet Oncology ,2012,13 ( 2 ) :e58-e68.
3Dworkin RH, Turk DC, Basch E, et al. Considerations for extrapola- ting evidence of acute and chronic pain analgesic efficacy [ J ]. Pain, 2011,152(8) :1705-1708.
4Holen JC, Lydersen S, Klepstad P,et al. The Brief Pain Inventory : pain' s interference with functions is different in cancer pain com- pared with noneancer chronic pain [ J ]. Clin J Pain, 2008,24 ( 3 ) : 219-225.
5Stjernsward J, Colleau SM, Ventafridda V. The World Health Or- ganization Cancer Pain and Palliative Care Program. Past, present, and future [ J ]. J Pain Symptom Manage, 1996,12 ( 2 ) :65 -72.
6U.S. Food and Drug Administration. Extended-Release (ER) and Long-Acting (LA) Opioid Analgesics Risk Evaluation and Mitigation Strategy (REMS) [ M ]. MD : Silver Spring,2013.
7Brogan S, Junkins S. Interventional therapies for the management of cancer pain [ J ]. J Support Oncol, 2010,8 ( 2 ) :52-59.
8Sheinfeld Gorin S, Krebs P, Badr H, et al. Meta-analysis of psychoso- cial interventions to reduce pain in patients with cancer [ J ]. J Clin Onco1,2012,30 (5) :539-547.
9Amtmann D, Cook KF, Jensen MP, et al. Development of a PROMIS item bank to measure pain interference [ J]. Pain,2010, 150 (1) : 173-182.
10Ware IA, Epps CD, Herr K, et al. Evaluation of the Revised Faces Pain Scale, Verbal Descriptor Scale, Numeric Rating Scale, and Io- wa Pain Thermometer in older minority adults [ J ]. Pain Manag Nuts, 2006,7(3) :117-125.
4Xu JM,Song ST,Feng FY,et al.Cobrotoxinconta-ining analgesic compound to treat chronic moderateto severe cancer pain:results from a randomized,double-blind,cross-over study and from an open-label study.Oncol Rep,2006,16:1077-1084.
